Related Experiment Video
Updated: Aug 11, 2026
09:45
Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
Published on: March 31, 2015
Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma
M Mullarkey1, C J Breen, M McDermott
1National Centre for Medical Genetics, Our Lady's Hospital for Sick Children, Crumlin, Dublin, Ireland.
Cytogenetics and Cell Genetics
|April 30, 2002
Summary
Comparative genomic hybridization revealed genetic changes in hepatoblastoma before and after chemotherapy. Gains in chromosomes 8q and 20 were linked to a poorer prognosis in this pediatric cancer.
Area of Science:
- Pediatric Oncology
- Cancer Genomics
- Genomic Instability
Background:
- Hepatoblastoma is a rare pediatric liver cancer with diverse histological patterns.
- Chemotherapy is a standard treatment, but its impact on tumor genetics is not fully understood.
- Understanding genetic alterations in hepatoblastoma is crucial for prognosis and treatment strategies.
Purpose of the Study:
- To compare the genomic profiles of a hepatoblastoma before and after chemotherapy using comparative genomic hybridization (CGH).
- To identify specific genetic gains and losses associated with treatment response and tumor progression.
- To correlate observed genetic changes with clinical outcomes and known prognostic markers.
Main Methods:
- Comparative genomic hybridization (CGH) analysis was performed on pre- and post-chemotherapy tumor samples.
- Histopathological examination of diagnostic biopsy and metastatic nodules was conducted.
- Genetic alterations (gains and losses) were identified and compared between the two time points.
Main Results:
- The pre-chemotherapy tumor showed gains in chromosomes 1q, 2, 2(q31q33), 7, 8q, 12(q15q22), 17q, and 20.
- The post-chemotherapy tumor exhibited gains in chromosomes 1q, 2, 7, 8q, 10, 17q, and 20.
- Key differences included localized gains of 2(q31q33) and 12(q15q22) in the pre-chemotherapy sample and gain of chromosome 10 in the post-chemotherapy sample.
- Metastatic nodules showed a similar histological pattern and genetic gains of 2(q31q33) and 12(q15q22).
- Loss of chromosome 17p material may have occurred in both samples.
Conclusions:
- Chemotherapy induced distinct genetic changes in hepatoblastoma, including the gain of chromosome 10.
- The persistence of gains in 2(q31q33) and 12(q15q22) in metastatic lesions suggests their role in tumor progression.
- Gains in chromosome 8q and 20 are associated with an unfavorable prognosis in hepatoblastoma, consistent with previous findings.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...